GLP-1 Drugs Show Promise Against Obesity-Linked Leukemia
New research suggests that GLP-1 receptor agonists, commonly prescribed for diabetes and weight loss, could be pivotal in a novel dual therapy to combat leukemia exacerbated by obesity.
Category
Search Results for
Latest stories, in-depth analysis & breaking updates
2+
Articles
Ozempic and Mounjaro makers point to unexpected anti-aging effects
New data from pharmaceutical giants Novo Nordisk and Eli Lilly suggests that GLP-1 medications could slow down molecular aging clocks by several years.
